Redispensing unused oral cancer drugs can have a beneficial impact on climate change, ecosystems, and human health, a study suggests.

Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say.

No statistical difference was reported in time to onset of CIPN between the 2 groups. Additionally, 75% of the patients undergoing treatment with gemcitabine plus albumin-bound paclitaxel did not ...

Study results support abandoning PSA testing beyond an uneventful period of 10 years after radical prostatectomy in patients with pT2 stage disease and a Gleason score less than or equal to 3 + 4, ...

Six high-risk clusters were identified with respect to county-level melanoma rate. HealthDay News — There is a negative association between travel time to tanning facilities and county-level melanoma ...

Postintervention and 3-month follow-up assessments were evaluated to determine the feasibility and effectiveness of GET in managing distress in young Latino men with testicular cancer.

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

High rates of overall response and MRD negativity were seen regardless of the dose patients received, said Andrew Spencer, MBBS.

There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online Oc ...

The United States launched the most new cancer drugs during the study period (n=345). Other countries with a high number of launches were Japan (n=224), Canada (n=221), Australia (n=204), the United ...

“This large dataset provided the opportunity to identify risk factors for [overall survival] post-relapse to inform trial design and highlight populations with dismal outcomes post-relapse,” the ...

An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.